60 Deg Pharma closes $5M public offering, up to $10M with warrant exercise

60 DEGREES PHARMACEUTICALS, INC.

Gross proceeds $5M from sale of 2,631,578 units (share/pre-funded warrant + warrants) at $1.90/unit.
Short-term Series A-2 warrants (18-mo term) could add $5M if fully cash-exercised; no guarantee.
Net proceeds earmarked for working capital and general corporate purposes.
H.C. Wainwright acted as exclusive placement agent; offering closed July 16, 2025.
Offering made under effective S-1 filed July 7, 2025 (SEC File No. 333-288550).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.